Company Sinopharm Group Co. Ltd.

1099

CNE100000FN7

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:03 2025-07-11 am EDT			5-day change	1st Jan Change
18.84 ^HKD	+0.64%		+1.73%	-11.55%

Jun. 12	Sinopharm Group Co. Ltd. Approves Board Appointments	CI
Jun. 10	Sinopharm Unit to Acquire 21% Stake in Pacific Shuanglin Bio-pharmacy	MT

Business description: Sinopharm Group Co. Ltd.

Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business.The Company operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.

Number of employees: 108,217

Sales by Activity: Sinopharm Group Co. Ltd.

Fiscal Period: December	2020	2021	2022	2023	2024
Pharmaceutical Distribution	348B	390B	407B	441B	444B
Medical Devices	89.4B	108B	121B	130B	118B
Retail Pharmacy	24.16B	29.06B	32.98B	35.69B	35.98B
Other Business	7.65B	9.82B	10.21B	10.39B	9.11B
Eliminations	-13.1B	-15.91B	-18.5B	-20.77B	-22.86B

See all business segments

Geographical breakdown of sales: Sinopharm Group Co. Ltd.

Fiscal Period: December	2020	2021	2022	2023	2024
People's Republic of China (PRC)	456B	521B	552B	597B	585B

See all geographic segments

Executive Committee: Sinopharm Group Co. Ltd.

Manager	Title	Age	Since
Wan Yong Lian PSD	President	55	2024-08-26
Yi Jian Wu SEC	Corporate Secretary	55	-
Xiu Chang Jiang DFI	Director of Finance/CFO	61	2010-04-30
Shuang Jun Xu PRN	Corporate Officer/Principal	56	2011-02-28
Zhong Xi Cai PRN	Corporate Officer/Principal	60	2010-04-30

See SINOPHARM GROUP CO. LTD. governance

Composition of the Board of Directors: Sinopharm Group Co. Ltd.

Director	Title	Age	Since
Qi Yu Chen BRD	Director/Board Member	53	2010-04-30
Zheng Dong Liu BRD	Director/Board Member	55	2014-09-20
De Yong Wen BRD	Director/Board Member	53	2017-08-31
Xiao Hui Guan CHM	Chairman	54	-
Rong Li Feng BRD	Director/Board Member	48	2020-06-10
Tak Lung Wu BRD	Director/Board Member	59	2020-09-17
Wei Feng Yu BRD	Director/Board Member	62	2020-09-17
Hai Qing Lu BRD	Director/Board Member	51	2020-09-17
Pei Yu Li BRD	Director/Board Member	62	2020-09-17
Sheng Hao Shi BRD	Director/Board Member	56	2023-06-14

Composition of the Board of Directors

Shareholders: Sinopharm Group Co. Ltd.

Name	Equities	%	Valuation
Lazard Asset Management LLC 9.058 %	121,547,064	9.058 %	285 M $
Fidelity Management & Research Co. LLC 5.299 %	71,104,795	5.299 %	166 M $
FIAM LLC 2.785 %	37,368,882	2.785 %	87 M $
BlackRock Fund Advisors 1.593 %	21,376,400	1.593 %	50 M $
JPMorgan Asset Management (Asia Pacific) Ltd. 1.584 %	21,247,600	1.584 %	50 M $

Name	Equities	%	Valuation
RhumbLine Advisers LP 0.00041 %	1,101	0.00041 %	12 889 $
GAMMA Investing LLC 0.000076 %	205	0.000076 %	2 400 $
PNC Investments LLC 0.000046 %	123	0.000046 %	1 440 $

Name	Equities	%	Valuation
Sinopharm Industrial Investment Co., Ltd. 88.35 %	1,571,555,953	88.35 %	3 680 M $
China State-Owned Assets Supervision & Admn Commission 11.65 %	207,289,498	11.65 %	485 M $

List of SINOPHARM GROUP CO. LTD. shareholders

Company details: Sinopharm Group Co. Ltd.

Sinopharm Group Co., Ltd.

Sinopharm Group Building No. 385, East Longhua Road

200023, Shanghai

+86 21 2305 2666

http://ir.sinopharmgroup.com.cn

Pharmaceuticals Wholesale

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
SINOPHARM GROUP CO. LTD.	+0.64%	+1.73%	-4.85%	-4.37%	7.44B
MCKESSON CORPORATION	-0.69%	-1.35%	+23.36%	+115.81%	89.39B
CARDINAL HEALTH, INC.	-0.74%	-2.40%	+70.41%	+203.77%	38.71B
SIGMA HEALTHCARE LIMITED	+0.35%	-4.98%	-	-	21.59B
HUADONG MEDICINE CO., LTD	+0.73%	-1.57%	+47.10%	-10.62%	9.72B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+1.60%	+5.97%	+0.32%	+2.76%	8.71B
GALENICA AG	-0.68%	-1.24%	+15.56%	+14.13%	5.52B
H. LUNDBECK A/S	+0.93%	-1.80%	-14.32%	-5.59%	5.21B
EBOS GROUP LIMITED	-0.50%	+1.72%	+20.12%	+3.69%	4.93B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+0.38%	+2.69%	+12.66%	+20.35%	3.7B
Average	+0.26%	+0.67%	+18.93%	+37.77%	19.49B
Weighted average by Cap.	-0.00%	-0.52%	+31.13%	+105.41%